Optimizing manufacturing and composition of a TLR4 nanosuspension: physicochemical stability and vaccine adjuvant activity

por Fung, HW Millie, Mikasa, Traci JT, Vergara, Julie, Sivananthan, Sandra J, Guderian, Jeffrey A, Duthie, Malcolm S, Vedvick, Thomas S, Fox, Christopher B
Publicado 2013

A nanoliposome delivery system to synergistically trigger TLR4 AND TLR7

por Fox, Christopher B, Sivananthan, Sandra J, Duthie, Malcolm S, Vergara, Julie, Guderian, Jeffrey A, Moon, Elliot, Coblentz, David, Reed, Steven G, Carter, Darrick
Publicado 2014

A structure-function approach to optimizing TLR4 ligands for human vaccines

por Carter, Darrick, Fox, Christopher B, Day, Tracey A, Guderian, Jeffrey A, Liang, Hong, Rolf, Tom, Vergara, Julie, Sagawa, Zachary K, Ireton, Greg, Orr, Mark T, Desbien, Anthony, Duthie, Malcolm S, Coler, Rhea N, Reed, Steven G
Publicado 2016

The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial

por Coler, Rhea N., Day, Tracey A., Ellis, Ruth, Piazza, Franco M., Beckmann, Anna Marie, Vergara, Julie, Rolf, Tom, Lu, Lenette, Alter, Galit, Hokey, David, Jayashankar, Lakshmi, Walker, Robert, Snowden, Margaret Ann, Evans, Tom, Ginsberg, Ann, Reed, Steven G.
Publicado 2018

Strategic evaluation of vaccine candidate antigens for the prevention of Visceral Leishmaniasis

por Duthie, Malcolm S., Favila, Michelle, Hofmeyer, Kimberley A., Tutterrow, Yeung L., Reed, Steven J., Laurance, John D., Picone, Alessandro, Guderian, Jeffrey, Bailor, H. Remy, Vallur, Aarthy C., Liang, Hong, Mohamath, Raodoh, Vergara, Julie, Howard, Randall F., Coler, Rhea N., Reed, Steven G.
Publicado 2016

Safety and immunogenicity of a thermostable ID93 + GLA-SE tuberculosis vaccine candidate in healthy adults

por Sagawa, Zachary K., Goman, Cristina, Frevol, Aude, Blazevic, Azra, Tennant, Janice, Fisher, Bridget, Day, Tracey, Jackson, Stephen, Lemiale, Franck, Toussaint, Leon, Kalisz, Irene, Jiang, Joe, Ondrejcek, Lisa, Mohamath, Raodoh, Vergara, Julie, Lew, Alan, Beckmann, Anna Marie, Casper, Corey, Hoft, Daniel F., Fox, Christopher B.
Publicado 2023

From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE

por Coler, Rhea N, Duthie, Malcolm S, Hofmeyer, Kimberly A, Guderian, Jeffery, Jayashankar, Lakshmi, Vergara, Julie, Rolf, Tom, Misquith, Ayesha, Laurance, John D, Raman, Vanitha S, Bailor, H Remy, Cauwelaert, Natasha Dubois, Reed, Steven J, Vallur, Aarthy, Favila, Michelle, Orr, Mark T, Ashman, Jill, Ghosh, Prakash, Mondal, Dinesh, Reed, Steven G
Publicado 2015

A defined subunit vaccine that protects against vector-borne visceral leishmaniasis

por Duthie, Malcolm S., Pereira, Lais, Favila, Michelle, Hofmeyer, Kimberly A., Reed, S. Jim, Metangmo, Sonia, Townsend, Shannon, Laurance, John D., Picone, Alessandro, Misquith, Ayesha, Hossain, Faria, Ghosh, Prakash, Khan, Md Anik Ashfaq, Guderian, Jeffery, Bailor, H. Remy, Liang, Hong, Vergara, Julie, Oliveira, Fabiano, Howard, Randall F., Kamhawi, Shaden, Mondal, Dinesh, Coler, Rhea N., Valenzuela, Jesus G., Reed, Steven G.
Publicado 2017